4/A
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0000899243-16-021027
Options or other derivatives
- Director bought 1,000,000 shares at $22.35 ($22,350,000)
From the SEC's structured data for this filing
Trades in this filing
Wahlstrom Mats · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-02-29 | Purchase : show line 1 in the form 8.2% Senior Convertible Notes due 2022 | +1,000,000 | $22.35 | $22,350,000 | 1,000,000 | I |
Loading xslF345X03/doc4a.xml…